Rectal Acetaminophen Use During Oocyte Retrievals to Reduce Post-Operative Opioid Utilization
- Registration Number
- NCT03732469
- Lead Sponsor
- University of South Florida
- Brief Summary
The primary aim of this study is to evaluate the administration of rectal acetaminophen to current and standard anesthesia and analgesia protocol in oocyte retrievals would reduce postoperative utilization of opioids (Tylenol with codeine) in fertility patients.
- Detailed Description
As the opioid epidemic shows no sign of abating, this national crisis deserves careful attention from all medical subspecialties. This includes reproductive endocrinology and infertility (REI), where opioids are primarily utilized for intraoperative and postoperative pain management for outpatient procedures such as oocyte retrievals, operative hysteroscopy, and laparoscopic myomectomy. The purpose of this study is to evaluate whether the administration of rectal acetaminophen in addition to the current, standard anesthesia and analgesia protocol in oocyte retrievals can help decrease utilization of prescribed opioid at home following oocyte retrieval. Rectal acetaminophen will be used rather than conventional IV acetaminophen because of the lack of access to IV acetaminophen at the study institution. Rectal acetaminophen is appealing because it is cheap, readily available in most medical centers and there is the potential for increased analgesic benefit due to the proximity to the vaginal and ovarian tissue, as well as the possible benefit from the partial avoidance of hepatic first-pass metabolism. This trial has the potential to provide practice-changing clinical information to the field of REI. The information gained can even translate to other ambulatory procedures and guide clinical practice. The investigators hypothesize that participants given rectal acetaminophen in addition to standard anesthesia/analgesia at the end of their oocyte retrieval will use less amount of prescribed Tylenol with codeine 3 days after discharge from the surgery center compared those receiving standard anesthesia/analgesia for oocyte retrieval.
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- Female
- Target Recruitment
- 4
- Any female patient undergoing oocyte retrieval by transvaginal ultrasound-guided ovarian puncture
- Patients with chronic pain conditions such as fibromyalgia and sickle cell anemia.
- Patient with BMI greater than 40
- Patients that required general endotracheal intubation anesthesia in prior oocyte retrieval
- Patients with documented allergic reaction to acetaminophen
- Patient with contra-indication to the use of acetaminophen (liver disease)
- Patients with a history of past or current alcohol, drug or opioid abuse
- Patients with ulcerative colitis, Crohn's disease, or severe rectal hemorrhoids
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Fentanyl/propofol + acetaminophen Acetaminophen In addition to the weight-based intraoperative IV dose of propofol and fentanyl per standard TGH Anesthesiology protocol, one dose of 1300 mg of solid base rectal acetaminophen suppository (2 suppositories) will be administered at the end of oocyte retrieval. Fentanyl/propofol + acetaminophen Fentanyl In addition to the weight-based intraoperative IV dose of propofol and fentanyl per standard TGH Anesthesiology protocol, one dose of 1300 mg of solid base rectal acetaminophen suppository (2 suppositories) will be administered at the end of oocyte retrieval. Fentanyl/propofol only Fentanyl Participants in this arm will receive the weight-based intraoperative IV dose of propofol and fentanyl per standard TGH Anesthesiology protocol. Fentanyl/propofol + acetaminophen Propofol In addition to the weight-based intraoperative IV dose of propofol and fentanyl per standard TGH Anesthesiology protocol, one dose of 1300 mg of solid base rectal acetaminophen suppository (2 suppositories) will be administered at the end of oocyte retrieval. Fentanyl/propofol only Propofol Participants in this arm will receive the weight-based intraoperative IV dose of propofol and fentanyl per standard TGH Anesthesiology protocol.
- Primary Outcome Measures
Name Time Method Proportion of prescribed Tylenol with Codeine (Tylenol #3) utilized 72 hours following oocyte retrieval The proportion of prescribed Tylenol with Codeine (Tylenol #3) utilized 72 hours postoperatively will be assessed by telephone encounter. A total of 10 tablets of Tylenol #3 will be prescribed to each participant. Fewer Tylenol #3 used at the end of this time frame would indicate better outcome.
- Secondary Outcome Measures
Name Time Method Pain score in post-anesthesia care unit using the Visual Analog Scale 1-hour after oocyte retrieval The Visual Analog Scale will be used to assess postoperative pain 1-hour after egg retrieval. The scale will be in a range from 0 to 10, with 0 being no pain and 10 being unbearable pain. A lower score would indicate a better outcome.
24-hour pain score using the Visual Analog Scale 24 hours after oocyte retrieval The Visual Analog Scale will be used to assess pain 24 hours after egg retrieval. The scale will be in a range from 0 to 10, with 0 being no pain and 10 being unbearable pain. A lower score would indicate a better outcome.
48-hour pain score using the Visual Analog Scale measuring pain 48 hours after oocyte retrieval The Visual Analog Scale will be used to assess pain 48 hours after egg retrieval. The scale will be in a range from 0 to 10, with 0 being no pain and 10 being unbearable pain. A lower score would indicate a better outcome.
72-hour pain score using the Visual Analog Scale measuring pain 72 hours after oocyte retrieval The Visual Analog Scale will be used to assess pain 72 hours after egg retrieval. The scale will be in a range from 0 to 10, with 0 being no pain and 10 being unbearable pain. A lower score would indicate a better outcome.
Trial Locations
- Locations (1)
University of South Florida
🇺🇸Tampa, Florida, United States